Primary Support for Infant Respiratory Distress Syndrome (RDS)2019-06-24T05:23:52-04:00

Momentum is building

Vapotherm is the only system shown to be as clinically effective as CPAP/Bi-Level and NIPPV in preventing intubations in preterm infants with RDS.
Read about the clinical trial

Preventing Intubation
Experienced female doctor

Demonstrated safety in large randomized controlled trials

All neonatal randomized controlled trials using Vapotherm showed no increased rate of pneumothoraces when compared to nCPAP, Bi-Level, and NIPPV. The pressure generated is safe when the cannula is sized appropriately to occlude less than 50% of the nares.

Parents will see their baby smile

Hi-VNI® Technology provides effective non-invasive respiratory support. The technology augments breathing to improve alveolar ventilation by:

  • Dead space washout of CO2 during exhalation
  • Precise FiO2 delivery during inhalation

These groundbreaking therapy advancements make it possible to support babies without masks or tight-fitting prongs. You’ll see the smiles, too.
Download Neonatal Best Practices Guide

Reduce Nasal Trauma

Vapotherm is user-friendly, so you can focus on helping babies thrive

Switching between CPAP masks and prongs to mitigate skin breakdown? Protect your babies’ skin with the comfortable Vapotherm cannulas.
Get a Demo

Go to Top